Nasal delivery systems and their effect on deposition and absorption

被引:162
作者
Kublik, H [1 ]
Vidgren, MT
机构
[1] Astra BmbH, D-22876 Wedel, Germany
[2] Univ Kuopio, Dept Pharmaceut, FI-70211 Kuopio, Finland
[3] AB Draco, S-22100 Lund, Sweden
关键词
nasal drug delivery; device; administration mode; formulation; deposition; distribution; clearance; absorption;
D O I
10.1016/S0169-409X(97)00067-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Due to nasal anatomy and physiology, with a non-ciliated area in the anterior part of the nasal cavity and a ciliated region in the more posterior part of the nose, the site of deposition is of importance for the nasal mucociliary clearance and retainment of a formulation in the nose. Many drug delivery devices for nasal application of liquid, semisolid and solid formulations were investigated in respect to their deposition in the nasal cavity. The site of deposition and the deposition area depend on several parameters which are related to the delivery device, such as mode of administration, particle size of the formulation and velocity of the delivered particles. Several in vitro and in vivo methods have been used to study distribution and clearance of intranasally delivered therapeutics. The relationship between deposition, absorption and related bioavailability of the nasally applied formulation has been shown. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:157 / 177
页数:21
相关论文
共 72 条
[41]   ENHANCEMENT OF NASAL ABSORPTION OF INSULIN AND CALCITONIN USING POLYACRYLIC-ACID GEL [J].
MORIMOTO, K ;
MORISAKA, K ;
KAMADA, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (02) :134-136
[42]  
MYGIND N, 1978, Rhinology (Utrecht), V16, P79
[43]  
MYGIND N, 1979, NASAL ALLERGY, P257
[44]   ADVANTAGES OF PRESSURIZED CANISTER METERED DOSE INHALERS [J].
NEWHOUSE, M .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1991, 4 (03) :139-150
[45]  
Newman S P, 1982, Clin Phys Physiol Meas, V3, P1, DOI 10.1088/0143-0815/3/1/001
[46]  
NEWMAN S P, 1987, Rhinology (Utrecht), V25, P77
[47]  
Newman S P, 1988, Rhinology, V26, P111
[48]   THE NASAL DISTRIBUTION OF METERED DOSE INHALERS [J].
NEWMAN, SP ;
MOREN, F ;
CLARKE, SW .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1987, 101 (02) :127-132
[49]   THE DISTRIBUTION OF AN INTRANASAL INSULIN FORMULATION IN HEALTHY-VOLUNTEERS - EFFECT OF DIFFERENT ADMINISTRATION TECHNIQUES [J].
NEWMAN, SP ;
STEED, KP ;
HARDY, JG ;
WILDING, IR ;
HOOPER, G ;
SPARROW, RA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (08) :657-660
[50]   SCINTIGRAPHIC ASSESSMENT OF THE OROPHARYNGEAL AND NASAL DEPOSITIONS OF FUSAFUNGINE FROM A PRESSURIZED INHALER AND FROM A NOVEL PUMP SPRAY DEVICE [J].
NEWMAN, SP ;
STEED, KP ;
HOOPER, G ;
BRICKWELL, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (10) :818-821